Thyrocare Technologies Limited Share Price & Analysis
₹562.85▲ +1.32%Updated 21 Jul 2026, 05:01 pm IST
LTP
₹562.85
+1.32%
Open
₹—
High
₹568.5
Low
₹545.65
Close
₹562.85
52W High
₹578
52W Low
₹343
Volume
646K
Lot Size
1
Sector
Healthcare
Market Cap
₹8K Cr
Face Value
₹10
Mid Cap
Price Chart
Fundamentals
P/E
51.5
Sector P/E
54.4
P/B
15.52
EPS
₹10.24
ROE
28.4%
ROCE
35.4%
D/E Ratio
0.09
Div Yield
1.79%
Book Value
₹36.8
+
Strengths
- ✓Excellent return on equity (ROE 28.4%)
- ✓Efficient capital deployment (ROCE 35.4%)
- ✓Virtually debt-free
- ✓Regular dividends — yield 1.8%
−
Concerns
- ✗High premium to book value (P/B 15.5x)
- ✗Trading near 52-week high (₹578)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,944 | ₹4.6L Cr | 37.3 | 5.59 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹7,388 | ₹1.9L Cr | 73.4 | 11.71 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹5,040 | ₹1.6L Cr | 73.6 | 20.32 | 27.4 | 15.2 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,939 | ₹1.3L Cr | 64.9 | 13.56 | 22.1 | 17.9 | 0.88 |
| CIPLA Cipla Limited | ₹1,416 | ₹1.1L Cr | 30.1 | 3.32 | 11.6 | 15.5 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,123 | ₹1.1L Cr | 21 | 4.17 | 21.2 | 21.1 | 0.38 |
| LUPIN Lupin Limited | ₹2,405 | ₹1.1L Cr | 19.6 | 4.9 | 28.7 | 29.9 | 0.32 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
THYROCARE · as of Mar 2026
Promoters71.06%
FII2.41%▼0.36
DII14.97%▲0.29
Public11.57%▲0.08
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 71.11% | 71.11% | 71.11% | 71.11% | 71.06% | 71.06% |
| FII | 3.35% | 2.90% | 2.49% | 1.93% | 2.77% | 2.41% |
| DII | 13.89% | 14.88% | 14.89% | 14.79% | 14.68% | 14.97% |
| Public | 11.64% | 11.11% | 11.49% | 12.15% | 11.49% | 11.57% |
Corporate Events
Thyrocare Technologies Limited has informed the Exchange about Board Meeting to be held on July 23, 2026 to inter-alia consider and approve the Unaudited Standalone and Consolidated Financial results of the Company for the quarter ended June 30, 2026
Results22 Jul 2026
Dividend - Rs 7 Per Share
Dividend22 Jun 2026
Bonus 2:1
Bonus27 Nov 2025
Interim Dividend - Rs 7 Per Share
Dividend23 Oct 2025
Dividend - Rs 21 Per Share
Dividend24 Jul 2025
Dividend - Rs 18 Per Share
Dividend15 Aug 2024
Financials
Quarterly Results
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹224 Cr ▲14.3% | ₹196 Cr ▼9.7% | ₹217 Cr ▲12.4% | ₹193 Cr ▲3.2% | ₹187 Cr ▲12.7% | ₹166 Cr ▼6.2% | ₹177 Cr ▲12.7% | ₹157 Cr |
| Op. Profit | ₹75 Cr ▲29.3% | ₹58 Cr ▼18.3% | ₹71 Cr ▲22.4% | ₹58 Cr ▲1.8% | ₹57 Cr ▲35.7% | ₹42 Cr ▼12.5% | ₹48 Cr ▲14.3% | ₹42 Cr |
| OPM | 34.0% ▲13.3% | 30.0% ▼9.1% | 33.0% ▲10.0% | 30.0% ▲0.0% | 30.0% ▲20.0% | 25.0% ▼7.4% | 27.0% ▲0.0% | 27.0% |
| Net Profit | ₹49 Cr ▲75.0% | ₹28 Cr ▼41.7% | ₹48 Cr ▲26.3% | ₹38 Cr ▲72.7% | ₹22 Cr ▲15.8% | ₹19 Cr ▼26.9% | ₹26 Cr ▲8.3% | ₹24 Cr |
| EPS (₹) | 2.96 ▲62.6% | 1.82 ▼39.7% | 3.02 ▲23.3% | 2.45 ▲80.1% | 1.36 ▲13.3% | 1.2 ▼28.6% | 1.68 ▲10.5% | 1.52 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹829 Cr ▲20.7% | ₹687 Cr ▲20.1% | ₹572 Cr ▲8.5% | ₹527 Cr ▼10.5% | ₹589 Cr ▲19.0% | ₹495 Cr ▲14.1% | ₹434 Cr ▲7.7% | ₹403 Cr ▲13.2% | ₹356 Cr ▲17.1% | ₹304 Cr |
| Expenses | ₹566 Cr ▲13.7% | ₹498 Cr ▲15.3% | ₹432 Cr ▲7.2% | ₹403 Cr ▲14.2% | ₹353 Cr ▲9.3% | ₹323 Cr ▲23.8% | ₹261 Cr ▲4.8% | ₹249 Cr ▲17.5% | ₹212 Cr ▲12.2% | ₹189 Cr |
| Op. Profit | ₹263 Cr ▲38.4% | ₹190 Cr ▲35.7% | ₹140 Cr ▲13.8% | ₹123 Cr ▼47.9% | ₹236 Cr ▲38.0% | ₹171 Cr ▼1.7% | ₹174 Cr ▲13.0% | ₹154 Cr ▲6.2% | ₹145 Cr ▲26.1% | ₹115 Cr |
| OPM | 32.0% ▲14.3% | 28.0% ▲16.7% | 24.0% ▲4.3% | 23.0% ▼42.5% | 40.0% ▲14.3% | 35.0% ▼12.5% | 40.0% ▲5.3% | 38.0% ▼7.3% | 41.0% ▲7.9% | 38.0% |
| Other Income | ₹12 Cr ▼20.0% | ₹15 Cr ▲66.7% | ₹9 Cr ▲0.0% | ₹9 Cr ▼69.0% | ₹29 Cr ▲141.7% | ₹12 Cr ▲1100.0% | ₹1 Cr ▼90.9% | ₹11 Cr ▼47.6% | ₹21 Cr ▲240.0% | ₹-15 Cr |
| Interest | ₹4 Cr ▲0.0% | ₹4 Cr ▼33.3% | ₹6 Cr ▲20.0% | ₹5 Cr ▲66.7% | ₹3 Cr ▲200.0% | ₹1 Cr ▼50.0% | ₹2 Cr ▲100.0% | ₹1 Cr | ₹0 Cr | ₹0 Cr |
| Depreciation | ₹59 Cr ▲7.3% | ₹55 Cr ▲17.0% | ₹47 Cr ▲20.5% | ₹39 Cr ▲14.7% | ₹34 Cr ▲13.3% | ₹30 Cr ▼6.3% | ₹32 Cr ▲23.1% | ₹26 Cr ▲30.0% | ₹20 Cr ▲11.1% | ₹18 Cr |
| PBT | ₹213 Cr ▲46.9% | ₹145 Cr ▲51.0% | ₹96 Cr ▲7.9% | ₹89 Cr ▼61.0% | ₹228 Cr ▲50.0% | ₹152 Cr ▲8.6% | ₹140 Cr ▲1.4% | ₹138 Cr ▼4.8% | ₹145 Cr ▲76.8% | ₹82 Cr |
| Tax % | 24.0% ▼36.8% | 38.0% ▲35.7% | 28.0% ▲3.7% | 27.0% ▲17.4% | 23.0% ▼11.5% | 26.0% ▼29.7% | 37.0% ▼2.6% | 38.0% ▲5.6% | 36.0% ▼25.0% | 48.0% |
| Net Profit | ₹163 Cr ▲79.1% | ₹91 Cr ▲31.9% | ₹69 Cr ▲7.8% | ₹64 Cr ▼63.6% | ₹176 Cr ▲55.8% | ₹113 Cr ▲28.4% | ₹88 Cr ▲3.5% | ₹85 Cr ▼8.6% | ₹93 Cr ▲116.3% | ₹43 Cr |
| EPS (₹) | 10.24 ▲77.8% | 5.76 ▲29.4% | 4.45 ▲9.6% | 4.06 ▼63.4% | 11.1 ▲55.7% | 7.13 ▲27.8% | 5.58 ▲3.7% | 5.38 ▼7.1% | 5.79 ▲117.7% | 2.66 |
| Div Payout | 137.0% ▲12.3% | 122.0% ▼9.6% | 135.0% ▼8.8% | 148.0% ▲228.9% | 45.0% ▼61.5% | 117.0% ▲290.0% | 30.0% ▼75.8% | 124.0% ▲113.8% | 58.0% ▼53.6% | 125.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities | ||||||||||
| Equity Capital | ₹159 Cr ▲200.0% | ₹53 Cr ▲0.0% | ₹53 Cr ▲0.0% | ₹53 Cr ▲0.0% | ₹53 Cr ▲0.0% | ₹53 Cr ▲0.0% | ₹53 Cr ▲0.0% | ₹53 Cr ▼1.9% | ₹54 Cr ▲0.0% | ₹54 Cr |
| Reserves | ₹426 Cr ▼13.8% | ₹494 Cr ▲4.2% | ₹474 Cr ▼1.5% | ₹481 Cr ▲1.5% | ₹474 Cr ▲26.7% | ₹374 Cr ▲19.1% | ₹314 Cr ▼17.8% | ₹382 Cr ▼2.1% | ₹390 Cr ▲10.2% | ₹354 Cr |
| Borrowings | ₹51 Cr ▲104.0% | ₹25 Cr ▼40.5% | ₹42 Cr ▲82.6% | ₹23 Cr ▲9.5% | ₹21 Cr ▲162.5% | ₹8 Cr ▼33.3% | ₹12 Cr ▲500.0% | ₹2 Cr | ₹0 Cr | ₹0 Cr |
| Other Liabilities | ₹111 Cr ▼8.3% | ₹121 Cr ▲61.3% | ₹75 Cr ▲1.4% | ₹74 Cr ▲23.3% | ₹60 Cr ▼43.4% | ₹106 Cr ▲17.8% | ₹90 Cr ▲143.2% | ₹37 Cr ▲2.8% | ₹36 Cr ▲20.0% | ₹30 Cr |
| Total Liabilities | ₹747 Cr ▲7.8% | ₹693 Cr ▲7.6% | ₹644 Cr ▲1.9% | ₹632 Cr ▲4.1% | ₹607 Cr ▲12.2% | ₹541 Cr ▲15.4% | ₹469 Cr ▼1.3% | ₹475 Cr ▼0.8% | ₹479 Cr ▲9.4% | ₹438 Cr |
| Assets | ||||||||||
| Fixed Assets | ₹317 Cr ▲6.7% | ₹297 Cr ▼2.9% | ₹306 Cr ▲4.1% | ₹294 Cr ▲3.2% | ₹285 Cr ▲12.6% | ₹253 Cr ▼5.9% | ₹269 Cr ▼8.5% | ₹294 Cr ▼1.7% | ₹299 Cr ▲15.4% | ₹259 Cr |
| CWIP | ₹3 Cr ▼78.6% | ₹14 Cr ▲366.7% | ₹3 Cr ▲50.0% | ₹2 Cr ▼33.3% | ₹3 Cr ▼62.5% | ₹8 Cr ▲60.0% | ₹5 Cr ▲400.0% | ₹1 Cr | ₹0 Cr ▼100.0% | ₹17 Cr |
| Investments | ₹177 Cr ▲9.3% | ₹162 Cr ▲0.0% | ₹162 Cr ▲12.5% | ₹144 Cr ▼1.4% | ₹146 Cr ▲15.9% | ₹126 Cr ▲40.0% | ₹90 Cr ▼5.3% | ₹95 Cr ▼20.8% | ₹120 Cr ▲15.4% | ₹104 Cr |
| Other Assets | ₹250 Cr ▲13.6% | ₹220 Cr ▲27.2% | ₹173 Cr ▼9.9% | ₹192 Cr ▲11.0% | ₹173 Cr ▲12.3% | ₹154 Cr ▲46.7% | ₹105 Cr ▲25.0% | ₹84 Cr ▲40.0% | ₹60 Cr ▲3.4% | ₹58 Cr |
| Total Assets | ₹747 Cr ▲7.8% | ₹693 Cr ▲7.6% | ₹644 Cr ▲1.9% | ₹632 Cr ▲4.1% | ₹607 Cr ▲12.2% | ₹541 Cr ▲15.4% | ₹469 Cr ▼1.3% | ₹475 Cr ▼0.8% | ₹479 Cr ▲9.4% | ₹438 Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating CF | ₹213 Cr ▲11.5% | ₹191 Cr ▲13.7% | ₹168 Cr ▲30.2% | ₹129 Cr ▲14.2% | ₹113 Cr ▼1.7% | ₹115 Cr ▼31.5% | ₹168 Cr ▲68.0% | ₹100 Cr ▼6.5% | ₹107 Cr ▲18.9% | ₹90 Cr |
| Investing CF | ₹-23 Cr ▲56.6% | ₹-53 Cr ▲41.8% | ₹-91 Cr ▼133.3% | ₹-39 Cr ▼62.5% | ₹-24 Cr ▲51.0% | ₹-49 Cr ▼5000.0% | ₹1 Cr ▲108.3% | ₹-12 Cr ▲72.1% | ₹-43 Cr ▼2.4% | ₹-42 Cr |
| Financing CF | ₹-170 Cr ▼30.8% | ₹-130 Cr ▼52.9% | ₹-85 Cr ▲1.2% | ₹-86 Cr ▲3.4% | ₹-89 Cr ▼43.5% | ₹-62 Cr ▲62.4% | ₹-165 Cr ▼75.5% | ₹-94 Cr ▼46.9% | ₹-64 Cr ▼30.6% | ₹-49 Cr |
| Net Cash Flow | ₹21 Cr ▲162.5% | ₹8 Cr ▲200.0% | ₹-8 Cr ▼300.0% | ₹4 Cr | ₹0 Cr ▼100.0% | ₹4 Cr ▲0.0% | ₹4 Cr ▲180.0% | ₹-5 Cr | ₹0 Cr | ₹0 Cr |
| Free Cash Flow | ₹198 Cr ▲35.6% | ₹146 Cr ▲36.4% | ₹107 Cr ▲21.6% | ₹88 Cr ▼11.1% | ₹99 Cr ▲6.5% | ₹93 Cr ▼41.1% | ₹158 Cr ▲159.0% | ₹61 Cr ▼3.2% | ₹63 Cr ▲18.9% | ₹53 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 33d ▼15.4% | 39d ▲39.3% | 28d ▼52.5% | 59d ▲1.7% | 58d ▲75.8% | 33d ▲135.7% | 14d ▲27.3% | 11d ▲10.0% | 10d ▲25.0% | 8d |
| Inventory Days | 81d ▼9.0% | 89d ▼14.4% | 104d ▲67.7% | 62d ▲17.0% | 53d ▲1.9% | 52d ▼18.8% | 64d ▲6.7% | 60d ▼9.1% | 66d ▲1.5% | 65d |
| Days Payable | 109d ▼25.3% | 146d ▲65.9% | 88d ▲63.0% | 54d ▲50.0% | 36d ▼35.7% | 56d ▼17.6% | 68d ▲172.0% | 25d ▲0.0% | 25d ▲316.7% | 6d |
| Cash Conv. Cycle | 4d ▲122.2% | -18d ▼140.9% | 44d ▼34.3% | 67d ▼10.7% | 75d ▲158.6% | 29d ▲190.0% | 10d ▼78.3% | 46d ▼8.0% | 50d ▼25.4% | 67d |
| Working Capital Days | 19d ▲46.2% | 13d ▲85.7% | 7d ▼77.4% | 31d ▼24.4% | 41d ▲115.8% | 19d ▲337.5% | -8d ▼128.6% | 28d ▲180.0% | 10d ▼47.4% | 19d |
| ROCE | 35.0% ▲40.0% | 25.0% ▲38.9% | 18.0% ▲5.9% | 17.0% ▼59.5% | 42.0% ▲16.7% | 36.0% ▲2.9% | 35.0% ▲16.7% | 30.0% ▼9.1% | 33.0% ▲17.9% | 28.0% |
Source: Screener.in · Lower days = better efficiency
Related Analysis
Frequently Asked Questions
What is Thyrocare Technologies Limited share price today?▾
Thyrocare Technologies Limited (THYROCARE) is currently trading at ₹562.85 on NSE, up 1.32% as of the last market session. Prices update daily after market close on MarketNetra.
Is Thyrocare Technologies Limited available in F&O (Futures & Options)?▾
Yes, Thyrocare Technologies Limited (THYROCARE) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Thyrocare Technologies Limited 52-week high and low?▾
Thyrocare Technologies Limited's 52-week high is ₹578 and the 52-week low is ₹343. The current price of ₹562.85 is 2.6% below the 52W high.
What is Thyrocare Technologies Limited P/E ratio?▾
Thyrocare Technologies Limited's current P/E ratio is 51.5. This indicates the market is paying ₹51.5 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Thyrocare Technologies Limited options?▾
Thyrocare Technologies Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade THYROCARE options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.